Search

Displaying results 791 - 800 of 10000 in total
  1. Drug

    Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB10584
    ApprovedInvestigational

    Mixtures: -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE, , Suspension for InjectionCategories: Antiinfectives for Systemic Use
  2. Drug

    Burosumab

    go.drugbank.com/drugs/DB14012
    ApprovedInvestigational

    This is the first drug approved to treat adults and children ages 1 year and older with X-linked hypophosphatemia (XLH), which is a rare, inherited form of rickets. … X-linked hypophosphatemia causes low circulating levels of phosphorus in the blood.

    Categories: Drugs for Treatment of Bone DiseasesProducts: CRYSVITA 10 MG SOLUTION FOR INJECTION, CRYSVITA 20 MG SOLUTION FOR INJECTION
  3. Drug

    Denosumab

    go.drugbank.com/drugs/DB06643
    ApprovedInvestigational

    It further received additional indication approval to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer and women at high risk … for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer in September 2011 and in men with osteoporosis at high risk for fracture in September 2012.

    Categories: Drugs for Treatment of Bone DiseasesProducts: XGEVA 120mg Solution for Injection, XGEVA Solution for Injection 120 mg/vial
  4. Drug

    Cetylpyridinium

    go.drugbank.com/drugs/DB11073
    ApprovedInvestigational

    Its salt form, cetylpyridinium chloride, is typically found as an active ingredient in mouthwashes, toothpastes, lozenges, throat sprays, breath sprays, and nasal sprays. … In these products, it generally mediates an antiseptic activity and protective action against dental plaque and reducing gingivitis.

    Mixtures: BUCOSEPTOL N, QCare Rx Oral Cleansing and Suctioning SystemCategories: Compounds used in a research, industrial, or household setting, Antiinfectives and Antiseptics for Local Oral Treatment
  5. Drug

    Nitrogen

    go.drugbank.com/drugs/DB09152
    ApprovedInvestigationalVet approved

    Liquid nitrogen is used principally in cryotherapy for removal of diseased skin. … Nitrogen is a chemical element with symbol N and atomic number 7. At room temperature, it is a transparent, odorless diatomic gas.

    Mixtures: Lung Diffusion Test Mix No Ne Co, Co-NE-O2-N2 MixtureProducts: N/A, Nitrogen Nf
  6. Drug

    Benzyl benzoate

    go.drugbank.com/drugs/DB00676
    Approved

    It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties. … It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies.

    Categories: Compounds used in a research, industrial, or household settingInternational brands: Antiscabiosum für Kinder, BE BO
  7. Drug

    Nizatidine

    go.drugbank.com/drugs/DB00585
    Approved

    The drug is used for the treatment of duodenal ulcers.

    Categories: Drugs for Acid Related Disorders, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)Synonyms: N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamine
  8. Drug

    Pancuronium

    go.drugbank.com/drugs/DB01337
    Approved

    As a neuromuscular blocking agent it is more potent than curare but has less effect on the circulatory system and on histamine release. … A bis-quaternary steroid that is a competitive nicotinic antagonist.

    Products: Pavulon Inj 2mg/ml, Pavulon Inj 1mg/ml
  9. Drug

    Ammonium carbonate

    go.drugbank.com/drugs/DB15926
    ApprovedWithdrawn

    Synonyms: Carbonic acid, diammonium saltMixtures: SYBORG SALTS Smelling Salt, JACK Smelling Salts for Athletes and Eucalyptus Oil
  10. Drug

    Ocrelizumab

    go.drugbank.com/drugs/DB11988
    ApprovedInvestigational

    It was later approved by Health Canada in August 2017, making the drug the first available treatment for PPMS in both the US and Canada. … [A31739] Compared to non-humanized CD20 antibodies such as [rituximab], ocrelizumab is expected to be less immunogenic with repeated infusions, improving the benefit-to-risk profile for patients with MS

    Products: OCREVUS 300mg/10mL Concentrate for Solution for Infusion